Research output per year
Research output per year
Personal profile
Academic discipline
MEDICAL ONCOLOGY
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Giampaolo Tortora is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
-
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
Van De Haar, J., Ma, X., Ooft, S. N., Van Der Helm, P. W., Hoes, L. R., Mainardi, S., Pinato, D. J., Sun, K., Salvatore, L., Tortora, G., Zurlo, I. V., Leo, S., Giampieri, R., Berardi, R., Gelsomino, F., Merz, V., Mazzuca, F., Antonuzzo, L., Rosati, G., Stavraka, C., & 30 others, 2023, In: Nature Medicine. 29, p. 605-614 10 p.Research output: Contribution to journal › Article
-
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
Piro, G., Carbone, C., Agostini, A., Esposito, A., De Pizzol, M., Novelli, R., Allegretti, M., Aramini, A., Caggiano, A., Granitto, A., De Sanctis, F., Ugel, S., Corbo, V., Martini, M., Lawlor, R. T., Scarpa, A. & Tortora, G., 2023, In: British Journal of Cancer. 128, p. 331-341 11 p.Research output: Contribution to journal › Article
-
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
Rossi, E., Schinzari, G., Cellini, F., Balducci, M., Pasqualoni, M., Maiorano, B. A., Fionda, B., Longo, S., Deodato, F., Di Stefani, A., Peris, K., Gambacorta, M. A. & Tortora, G., 2023, In: Biomedicines. 11, p. 394-N/AResearch output: Contribution to journal › Article
-
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis
Chiricozzi, A., Di Nardo, L., Gori, N., Antonelli, F., Pinto, L. M., Cuffaro, G., Piro, G., Savino, G., Tortora, G. & Peris, K., 2023, In: Experimental Dermatology. 32, p. 1531-1537 7 p.Research output: Contribution to journal › Article
-
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients
Salvatore, L., Bensi, M., Vivolo, R., Zurlo, I. V., Dell’Aquila, E., Grande, R., Anghelone, A., Emiliani, A., Citarella, F., Calegari, M. A., Ribelli, M., Basso, M., Pozzo, C. & Tortora, G., 2023, In: Frontiers in Oncology. 13, p. 1125013-N/AResearch output: Contribution to journal › Article